Designed by
Title
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase #191120407
Description
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Conventional skeletal formula and stylized representation, showing atoms (except hydrogen) as color coded circles